Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |
ALKSAlkermes | $4.12bn | 6.91 | n/a |
ALKSVAlkermes | $4.05bn | 18.02 | n/a |
CRNXCrinetics Pharmaceuticals | $3.90bn | n/a | n/a |
RYZBRayzebio | $3.81bn | n/a | n/a |
CBAYCymaBay Therapeutics | $3.73bn | n/a | n/a |
ALVOAlvotech SA | $3.72bn | n/a | n/a |
INSMInsmed | $3.65bn | n/a | n/a |
BHVNBiohaven | $3.42bn | n/a | n/a |
RAREUltragenyx Pharmaceutical | $3.37bn | n/a | n/a |
SWTXSpringWorks Therapeutics | $3.18bn | n/a | n/a |
ARWRArrowhead Pharmaceuticals | $3.11bn | n/a | n/a |
IDYAIdeaya Biosciences | $3.10bn | n/a | n/a |
SMMTSummit Therapeutics | $3.08bn | n/a | n/a |
PTCTPTC Therapeutics | $2.98bn | n/a | n/a |
XENEXenon Pharmaceuticals | $2.94bn | n/a | n/a |
FOLDAmicus Therapeutics | $2.94bn | n/a | n/a |
KDNYChinook Therapeutics | $2.90bn | n/a | n/a |
IOVAIovance Biotherapeutics | $2.89bn | n/a | n/a |
GHGuardant Health | $2.88bn | n/a | n/a |